Listing 1 - 10 of 11 | << page >> |
Sort by
|
Choose an application
Choose an application
Fallow deer --- Lek behavior --- Environmental aspects --- Environmental aspects
Choose an application
599.735.3 --- 591.55 --- Cervicornia. Antlered mammals. Deer. Roe-deer. Fallow-deer. Red deer etc. Musk-deer. Elk (moose). Wapiti. Reindeer (caribou) --- Communal life. Animal societies --- 591.55 Communal life. Animal societies --- 599.735.3 Cervicornia. Antlered mammals. Deer. Roe-deer. Fallow-deer. Red deer etc. Musk-deer. Elk (moose). Wapiti. Reindeer (caribou)
Choose an application
Cattle --- Cattle --- Goats --- Goats --- Sheep --- Sheep --- horses --- horses --- Bison --- Bison --- Cervidae --- Cervidae --- Wild boar --- Wild boar --- Fallow deer --- Fallow deer --- Llamas --- Llamas --- Vicunas --- Vicunas --- Asses --- Asses --- Mules --- Mules --- Meat animals --- Meat animals --- Milk yielding animals --- Milk yielding animals --- working animals --- working animals --- skin producing animals --- skin producing animals --- animal husbandry --- animal husbandry --- Production --- Production --- Filiere --- Auroche --- France --- France --- Filiere --- Auroche
Choose an application
Chevreuil --- Roe deer --- Dynamique des populations --- population dynamics --- Densité de population --- population density --- Mortalité --- Mortality --- forests --- Protection des peuplements --- Stand protection --- United Kingdom --- 599.735.3 --- 639.111.12 --- 639.1.04 --- Cervicornia. Antlered mammals. Deer. Roe-deer. Fallow-deer. Red deer etc. Musk-deer. Elk (moose). Wapiti. Reindeer (caribou) --- Rearing and care of game --- 639.1.04 Rearing and care of game --- 639.111.12 Roe deer --- 599.735.3 Cervicornia. Antlered mammals. Deer. Roe-deer. Fallow-deer. Red deer etc. Musk-deer. Elk (moose). Wapiti. Reindeer (caribou)
Choose an application
Babesiosis, caused by tick-transmitted intraerythrocytic parasites (Babesia spp.), occurs worldwide. The disease mainly affects livestock, but records of infections in humans are increasing, and the disease is considered to be emerging worldwide. This book provides a comprehensive and holistic view of Babesia species that can infect humans. Numerous experts analyze, in detail, basic aspects of the biology of Babesia, the pathology of the babesiosis highlighting the pathogenesis of babesiosis in sickle cell, the eco-epidemiology of tick vectors and the impact of climate change on them, the current status, and future prospects for laboratory diagnosis and measures to prevent transfusion transmission. The book also focused on unidentified Babesia parasites that continue to emerge, most likely from wildlife, for which neither tick vector species nor vertebrate reservoir host species are currently known. Lastly, current and new therapies for infected patients, in vitro and in vivo culture systems for antibabesial evaluation and measures to prevent infections are also considered.
Medicine --- Epidemiology & medical statistics --- babesiosis --- Babesia microti --- Babesia duncani --- parasite --- therapy --- atovaquone --- endochin-like quinolones (ELQs) --- human babesiosis --- Nantucket Island --- epidemiology --- ecology --- human risk --- European babesiosis --- Babesia divergens --- Babesia venatorum --- Ixodes ricinus --- parasite identity --- clinical cases --- diagnosis --- treatment --- Babesia --- diversity --- phylogenetic analysis --- blood transfusion --- prevention --- screening --- aspartyl protease --- plasmepsin --- apicomplexa --- piroplasmida --- BmIPA48 --- BMR1_03g00960 --- piroplasmid rhoptry-associated protein-1 (pRAP-1) --- ticks --- Babesia sp. --- biological cycle --- experimental transmission --- experimental models --- Ixodes scapularis --- climate --- global warming --- Babesia sp. MO1 --- Babesia capreoli --- rap-1a --- ama-1 --- phylogeny --- sickle-cell anemia --- hemolysis --- haemoglobinopathies --- immunoepidemiology --- case surveillance --- therapeutic drugs --- peptidases --- antibody-based assays --- nucleic acid tests --- multiplex detection --- next generation sequencing --- glycosylphosphatidylinositol --- protein structure --- antigen --- host blood analysis --- fallow deer --- ixodid ticks --- piroplasm --- red deer --- Theileria --- Babesia bovis --- Babesia bigemina --- Colombia --- n/a --- in vitro culture --- erythrocytes --- DMEM-F12 --- virulence
Choose an application
Babesiosis, caused by tick-transmitted intraerythrocytic parasites (Babesia spp.), occurs worldwide. The disease mainly affects livestock, but records of infections in humans are increasing, and the disease is considered to be emerging worldwide. This book provides a comprehensive and holistic view of Babesia species that can infect humans. Numerous experts analyze, in detail, basic aspects of the biology of Babesia, the pathology of the babesiosis highlighting the pathogenesis of babesiosis in sickle cell, the eco-epidemiology of tick vectors and the impact of climate change on them, the current status, and future prospects for laboratory diagnosis and measures to prevent transfusion transmission. The book also focused on unidentified Babesia parasites that continue to emerge, most likely from wildlife, for which neither tick vector species nor vertebrate reservoir host species are currently known. Lastly, current and new therapies for infected patients, in vitro and in vivo culture systems for antibabesial evaluation and measures to prevent infections are also considered.
babesiosis --- Babesia microti --- Babesia duncani --- parasite --- therapy --- atovaquone --- endochin-like quinolones (ELQs) --- human babesiosis --- Nantucket Island --- epidemiology --- ecology --- human risk --- European babesiosis --- Babesia divergens --- Babesia venatorum --- Ixodes ricinus --- parasite identity --- clinical cases --- diagnosis --- treatment --- Babesia --- diversity --- phylogenetic analysis --- blood transfusion --- prevention --- screening --- aspartyl protease --- plasmepsin --- apicomplexa --- piroplasmida --- BmIPA48 --- BMR1_03g00960 --- piroplasmid rhoptry-associated protein-1 (pRAP-1) --- ticks --- Babesia sp. --- biological cycle --- experimental transmission --- experimental models --- Ixodes scapularis --- climate --- global warming --- Babesia sp. MO1 --- Babesia capreoli --- rap-1a --- ama-1 --- phylogeny --- sickle-cell anemia --- hemolysis --- haemoglobinopathies --- immunoepidemiology --- case surveillance --- therapeutic drugs --- peptidases --- antibody-based assays --- nucleic acid tests --- multiplex detection --- next generation sequencing --- glycosylphosphatidylinositol --- protein structure --- antigen --- host blood analysis --- fallow deer --- ixodid ticks --- piroplasm --- red deer --- Theileria --- Babesia bovis --- Babesia bigemina --- Colombia --- n/a --- in vitro culture --- erythrocytes --- DMEM-F12 --- virulence
Choose an application
Babesiosis, caused by tick-transmitted intraerythrocytic parasites (Babesia spp.), occurs worldwide. The disease mainly affects livestock, but records of infections in humans are increasing, and the disease is considered to be emerging worldwide. This book provides a comprehensive and holistic view of Babesia species that can infect humans. Numerous experts analyze, in detail, basic aspects of the biology of Babesia, the pathology of the babesiosis highlighting the pathogenesis of babesiosis in sickle cell, the eco-epidemiology of tick vectors and the impact of climate change on them, the current status, and future prospects for laboratory diagnosis and measures to prevent transfusion transmission. The book also focused on unidentified Babesia parasites that continue to emerge, most likely from wildlife, for which neither tick vector species nor vertebrate reservoir host species are currently known. Lastly, current and new therapies for infected patients, in vitro and in vivo culture systems for antibabesial evaluation and measures to prevent infections are also considered.
Medicine --- Epidemiology & medical statistics --- babesiosis --- Babesia microti --- Babesia duncani --- parasite --- therapy --- atovaquone --- endochin-like quinolones (ELQs) --- human babesiosis --- Nantucket Island --- epidemiology --- ecology --- human risk --- European babesiosis --- Babesia divergens --- Babesia venatorum --- Ixodes ricinus --- parasite identity --- clinical cases --- diagnosis --- treatment --- Babesia --- diversity --- phylogenetic analysis --- blood transfusion --- prevention --- screening --- aspartyl protease --- plasmepsin --- apicomplexa --- piroplasmida --- BmIPA48 --- BMR1_03g00960 --- piroplasmid rhoptry-associated protein-1 (pRAP-1) --- ticks --- Babesia sp. --- biological cycle --- experimental transmission --- experimental models --- Ixodes scapularis --- climate --- global warming --- Babesia sp. MO1 --- Babesia capreoli --- rap-1a --- ama-1 --- phylogeny --- sickle-cell anemia --- hemolysis --- haemoglobinopathies --- immunoepidemiology --- case surveillance --- therapeutic drugs --- peptidases --- antibody-based assays --- nucleic acid tests --- multiplex detection --- next generation sequencing --- glycosylphosphatidylinositol --- protein structure --- antigen --- host blood analysis --- fallow deer --- ixodid ticks --- piroplasm --- red deer --- Theileria --- Babesia bovis --- Babesia bigemina --- Colombia --- in vitro culture --- erythrocytes --- DMEM-F12 --- virulence --- babesiosis --- Babesia microti --- Babesia duncani --- parasite --- therapy --- atovaquone --- endochin-like quinolones (ELQs) --- human babesiosis --- Nantucket Island --- epidemiology --- ecology --- human risk --- European babesiosis --- Babesia divergens --- Babesia venatorum --- Ixodes ricinus --- parasite identity --- clinical cases --- diagnosis --- treatment --- Babesia --- diversity --- phylogenetic analysis --- blood transfusion --- prevention --- screening --- aspartyl protease --- plasmepsin --- apicomplexa --- piroplasmida --- BmIPA48 --- BMR1_03g00960 --- piroplasmid rhoptry-associated protein-1 (pRAP-1) --- ticks --- Babesia sp. --- biological cycle --- experimental transmission --- experimental models --- Ixodes scapularis --- climate --- global warming --- Babesia sp. MO1 --- Babesia capreoli --- rap-1a --- ama-1 --- phylogeny --- sickle-cell anemia --- hemolysis --- haemoglobinopathies --- immunoepidemiology --- case surveillance --- therapeutic drugs --- peptidases --- antibody-based assays --- nucleic acid tests --- multiplex detection --- next generation sequencing --- glycosylphosphatidylinositol --- protein structure --- antigen --- host blood analysis --- fallow deer --- ixodid ticks --- piroplasm --- red deer --- Theileria --- Babesia bovis --- Babesia bigemina --- Colombia --- in vitro culture --- erythrocytes --- DMEM-F12 --- virulence
Choose an application
Foamy viruses, currently referred to as spumaretroviruses, are the most ancient retroviruses as evidenced by traces of viral sequences dispersed in all vertebrate classes from fish to mammals. Additionally, infectious foamy viruses circulate in a variety of mammalian species including simian, bovine, equine, caprine, and feline. Foamy viruses have many unique features which led to the division of the retrovirus family into two subfamilies, the Orthoretrovirinae and Spumaretrovirinae. In vitro, foamy viruses have a broad host range and in vivo, human infections have been described due to cross-species transmission from infected nonhuman primates. Thus far, there are no reports of virus-induced disease in humans or in the natural host species. These unique properties of foamy viruses have led researchers to develop foamy viruses as gene therapy vectors to study virus–virus and virus–host interactions for identifying factors involved in virus replication, transmission, and immune regulation that could influence potential clinical outcomes in humans as well as for using endogenous foamy virus sequences in the analysis of host species evolution.
Medicine --- Neurosciences --- spumavirus --- feline illness --- proviral load --- neglected virus --- bovine foamy virus --- infectious clone --- particle release --- cell-free transmission --- foamy virus --- spumaretrovirus --- cross-species virus transmission --- zoonosis --- restriction factors --- immune responses --- FV vectors --- virus replication --- latent infection --- feline foamy virus --- epidemiology --- retrovirus --- Spumaretrovirus --- mountain lion --- Puma concolor --- ELISA --- protease --- reverse transcriptase --- RNase H --- reverse transcription --- antiviral drugs --- resistance --- simian foamy virus --- gibbon --- lesser apes --- co-evolution --- complete viral genome --- equine foamy virus --- isolation --- Japan --- sero-epidemiology --- reptile foamy virus --- endogenous foamy virus --- endogenous retrovirus --- ancient retroviruses --- co-speciation --- foamy virus-host interactions --- viral tropism --- infection --- kidney --- cats --- chronic kidney disease --- chronic renal disease --- integrase --- integration --- co-infections --- NHP --- pathogenesis --- zoonoses --- viral prevalence --- Neotropical primates --- free-living primates --- Brazil --- new world primates --- simian retrovirus --- BFV --- spuma virus --- model system --- animal model --- animal experiment --- miRNA function --- gene expression --- antiviral host restriction --- gene therapy --- in-vivo gene therapy --- hematopoietic stem and progenitor cells --- foamy virus vector --- pre-clinical canine model --- SCID-X1 --- innate sensing --- cGAS --- STING --- foamy viruses --- wild ruminants --- European bison --- red deer --- roe deer --- fallow deer --- seroreactivity --- inter-species transmission --- HSC --- gene marking --- FV gene transfer to HSCs --- gene therapy alternatives --- serotype --- high-throughput sequencing --- replication kinetics --- cytopathic effect --- reverse transcriptase activity --- miRNA expression --- virus-host-interaction --- miRNA target gene identification --- innate immunity --- ANKRD17 --- Bif1 (SH3GLB1) --- replication in vitro --- spumavirus --- feline illness --- proviral load --- neglected virus --- bovine foamy virus --- infectious clone --- particle release --- cell-free transmission --- foamy virus --- spumaretrovirus --- cross-species virus transmission --- zoonosis --- restriction factors --- immune responses --- FV vectors --- virus replication --- latent infection --- feline foamy virus --- epidemiology --- retrovirus --- Spumaretrovirus --- mountain lion --- Puma concolor --- ELISA --- protease --- reverse transcriptase --- RNase H --- reverse transcription --- antiviral drugs --- resistance --- simian foamy virus --- gibbon --- lesser apes --- co-evolution --- complete viral genome --- equine foamy virus --- isolation --- Japan --- sero-epidemiology --- reptile foamy virus --- endogenous foamy virus --- endogenous retrovirus --- ancient retroviruses --- co-speciation --- foamy virus-host interactions --- viral tropism --- infection --- kidney --- cats --- chronic kidney disease --- chronic renal disease --- integrase --- integration --- co-infections --- NHP --- pathogenesis --- zoonoses --- viral prevalence --- Neotropical primates --- free-living primates --- Brazil --- new world primates --- simian retrovirus --- BFV --- spuma virus --- model system --- animal model --- animal experiment --- miRNA function --- gene expression --- antiviral host restriction --- gene therapy --- in-vivo gene therapy --- hematopoietic stem and progenitor cells --- foamy virus vector --- pre-clinical canine model --- SCID-X1 --- innate sensing --- cGAS --- STING --- foamy viruses --- wild ruminants --- European bison --- red deer --- roe deer --- fallow deer --- seroreactivity --- inter-species transmission --- HSC --- gene marking --- FV gene transfer to HSCs --- gene therapy alternatives --- serotype --- high-throughput sequencing --- replication kinetics --- cytopathic effect --- reverse transcriptase activity --- miRNA expression --- virus-host-interaction --- miRNA target gene identification --- innate immunity --- ANKRD17 --- Bif1 (SH3GLB1) --- replication in vitro
Choose an application
Foamy viruses, currently referred to as spumaretroviruses, are the most ancient retroviruses as evidenced by traces of viral sequences dispersed in all vertebrate classes from fish to mammals. Additionally, infectious foamy viruses circulate in a variety of mammalian species including simian, bovine, equine, caprine, and feline. Foamy viruses have many unique features which led to the division of the retrovirus family into two subfamilies, the Orthoretrovirinae and Spumaretrovirinae. In vitro, foamy viruses have a broad host range and in vivo, human infections have been described due to cross-species transmission from infected nonhuman primates. Thus far, there are no reports of virus-induced disease in humans or in the natural host species. These unique properties of foamy viruses have led researchers to develop foamy viruses as gene therapy vectors to study virus–virus and virus–host interactions for identifying factors involved in virus replication, transmission, and immune regulation that could influence potential clinical outcomes in humans as well as for using endogenous foamy virus sequences in the analysis of host species evolution.
Medicine --- Neurosciences --- spumavirus --- feline illness --- proviral load --- neglected virus --- bovine foamy virus --- infectious clone --- particle release --- cell-free transmission --- foamy virus --- spumaretrovirus --- cross-species virus transmission --- zoonosis --- restriction factors --- immune responses --- FV vectors --- virus replication --- latent infection --- feline foamy virus --- epidemiology --- retrovirus --- Spumaretrovirus --- mountain lion --- Puma concolor --- ELISA --- protease --- reverse transcriptase --- RNase H --- reverse transcription --- antiviral drugs --- resistance --- simian foamy virus --- gibbon --- lesser apes --- co-evolution --- complete viral genome --- equine foamy virus --- isolation --- Japan --- sero-epidemiology --- reptile foamy virus --- endogenous foamy virus --- endogenous retrovirus --- ancient retroviruses --- co-speciation --- foamy virus-host interactions --- viral tropism --- infection --- kidney --- cats --- chronic kidney disease --- chronic renal disease --- integrase --- integration --- co-infections --- NHP --- pathogenesis --- zoonoses --- viral prevalence --- Neotropical primates --- free-living primates --- Brazil --- new world primates --- simian retrovirus --- BFV --- spuma virus --- model system --- animal model --- animal experiment --- miRNA function --- gene expression --- antiviral host restriction --- gene therapy --- in-vivo gene therapy --- hematopoietic stem and progenitor cells --- foamy virus vector --- pre-clinical canine model --- SCID-X1 --- innate sensing --- cGAS --- STING --- foamy viruses --- wild ruminants --- European bison --- red deer --- roe deer --- fallow deer --- seroreactivity --- inter-species transmission --- HSC --- gene marking --- FV gene transfer to HSCs --- gene therapy alternatives --- serotype --- high-throughput sequencing --- replication kinetics --- cytopathic effect --- reverse transcriptase activity --- miRNA expression --- virus-host-interaction --- miRNA target gene identification --- innate immunity --- ANKRD17 --- Bif1 (SH3GLB1) --- replication in vitro
Listing 1 - 10 of 11 | << page >> |
Sort by
|